User profiles for David Brooks

David J Brooks

- Verified email at newcastle.ac.uk - Cited by 158848

David Brooks

- Verified email at eecs.harvard.edu - Cited by 23772

[BOOK][B] Bobos in paradise: The new upper class and how they got there

D Brooks - 2010 - books.google.com
In his bestselling work of “comic sociology,” David Brooks coins a new word, Bobo, to describe
today’s upper class—those who have wed the bourgeois world of capitalist enterprise to …

Wattch: A framework for architectural-level power analysis and optimizations

D Brooks, V Tiwari, M Martonosi - ACM SIGARCH Computer Architecture …, 2000 - dl.acm.org
Power dissipation and thermal issues are increasingly significant in modern processors. As
a result, it is crucial that power/performance tradeoffs be made more visible to chip architects …

The Parkinson progression marker initiative (PPMI)

…, A Singleton, K Hawkins, J Eberling, D Brooks… - Progress in …, 2011 - Elsevier
The Parkinson Progression Marker Initiative (PPMI) is a comprehensive observational,
international, multi-center study designed to identify PD progression biomarkers both to improve …

Cross talk between signaling pathways in pathogen defense

BN Kunkel, DM Brooks - Current opinion in plant biology, 2002 - Elsevier
Plant defense in response to microbial attack is regulated through a complex network of
signaling pathways that involve three signaling molecules: salicylic acid (SA), jasmonic acid (JA) …

Neuroinflammation in Alzheimer's disease

…, VH Perry, C Holmes, NG Bazan, DJ Brooks… - The Lancet …, 2015 - thelancet.com
Increasing evidence suggests that Alzheimer's disease pathogenesis is not restricted to the
neuronal compartment, but includes strong interactions with immunological mechanisms in …

Prevalence of cerebral amyloid pathology in persons without dementia: a meta-analysis

…, BNM Van Berckel, K Bibeau, K Blennow, DJ Brooks… - Jama, 2015 - jamanetwork.com
Importance Cerebral amyloid-β aggregation is an early pathological event in Alzheimer
disease (AD), starting decades before dementia onset. Estimates of the prevalence of amyloid …

[HTML][HTML] A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa

O Rascol, DJ Brooks, AD Korczyn… - … England Journal of …, 2000 - Mass Medical Soc
Background There is debate about whether the initial treatment for patients with Parkinson's
disease should be levodopa or a dopamine agonist. Methods In this prospective, …

Evidence for striatal dopamine release during a video game

…, VJ Cunningham, A Dagher, T Jones, DJ Brooks… - Nature, 1998 - nature.com
Dopaminergic neurotransmission may be involved in learning, reinforcement of behaviour,
attention, and sensorimotor integration 1 , 2 . Binding of the radioligand 11 C-labelled …

Inflammation after trauma: microglial activation and traumatic brain injury

AF Ramlackhansingh, DJ Brooks… - Annals of …, 2011 - Wiley Online Library
Objective: Patient outcome after traumatic brain injury (TBI) is highly variable. The underlying
pathophysiology of this is poorly understood, but inflammation is potentially an important …

Direct brain infusion of glial cell line–derived neurotrophic factor in Parkinson disease

…, K O'Sullivan, R McCarter, M Bunnage, DJ Brooks… - Nature medicine, 2003 - nature.com
Glial cell line–derived neurotrophic factor (GDNF) is a potent neurotrophic factor with
restorative effects in a wide variety of rodent and primate models of Parkinson disease, but …